Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Stoppen versus continueren van RAS-remmers bij COVID-19
okt 2021 | Virale infecties